Levodropropizine is a peripheral antitussive agent belonging to the piperazine class, used to treat cough by inhibiting sensory neuropeptide release rather than acting on the central nervous system. As… Read more







Levodropropizine is a peripheral antitussive agent belonging to the piperazine class, used to treat cough by inhibiting sensory neuropeptide release rather than acting on the central nervous system. As the levo-isomer of dropropizine, it is a significant focus for pharmaceutical research. Laboratories utilize this collection of Levodropropizine reference standards, impurities, and metabolites to support critical analytical workflows. These include impurity profiling, method validation, and quality control during the development of antitussive formulations. The selection encompasses key degradation products and synthetic by-products, such as N-oxides and phenylpiperazine derivatives, as well as stable isotope labelled compounds like Levodropropizine-D8. By incorporating these high-quality materials into assays, scientists can ensure accurate quantification and regulatory compliance when conducting stability studies or confirming the chemical purity of active pharmaceutical ingredients.